Status:
UNKNOWN
Leukemic Stem Cell Detection for Chronic Myeloid Leukemia Patients With Major Molecular Response
Lead Sponsor:
Ankara University
Conditions:
Chronic Myeloid Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
Multi-Center, national, non-drug, prospective cohort study Target patient number is 100 The amount of CD45+/CD34+/CD38-/CD26+ levels of chronic myeloid leukemia (CML) stem cells in CML patients with a...
Detailed Description
In the present study, its aimed to compare the amount of CD45+/CD34+/CD38-/CD26+ levels of CML stem cells in CML patients with and without BCR-ABL hematopoiesis. Therefore, the amount of CD45+/CD34+/C...
Eligibility Criteria
Inclusion
- Newly diagnosed CML patients or patients with a previous diagnosis under follow-up with TKIs
Exclusion
- \-
Key Trial Info
Start Date :
August 13 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04104035
Start Date
August 13 2019
End Date
January 1 2021
Last Update
September 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara University
Ankara, Turkey (Türkiye)